美国STEMI患者诊疗流程与结局的机构间变异
直接就诊者59.5%达标≤90分钟,转运者50.3%达标≤120分钟,未达标与院内死亡风险升高相关,低绩效医院死亡风险亦增高。
要点
- 直接就诊者59.5%达标≤90分钟,转运者50.3%达标≤120分钟。
- 未达标者院内死亡风险升高:直接就诊aOR 2.21,转运aOR 2.44。
- 低绩效医院较高绩效医院死亡风险增高(aOR 1.16)。
核心结论
- STEMI患者FMC-to-device时间达标存在显著医院间变异,未达标和低绩效医院均与更差结局相关。
研究设计与样本
- 回顾性横断面研究,来自美国心脏协会GWTG-CAD注册研究2020–2022年503家美国医院。
主要发现
- 直接就诊达标率中位数60.8%(IQR 51.2%-68.8%),转运达标率中位数50.0%(IQR 32.5%-66.9%)。
- 未达标与院内死亡风险升高相关:直接就诊aOR 2.21(95%CI 2.02-2.42),转运aOR 2.44(95%CI 1.90-3.12)。
- 低绩效医院较高绩效医院直接就诊者死亡风险增高(aOR 1.16,95%CI 1.00-1.34)。
- 农村与城市医院达标 odds 无显著差异:直接就诊aOR 1.20(95%CI 0.96-1.50),转运aOR 0.86(95%CI 0.50-1.47)。
关键数值与推荐
- 直接就诊于PCI能力医院的目标FMC-to-device时间≤90分钟。
- 转运患者的目标FMC-to-device时间≤120分钟。
临床怎么用
- 应将FMC-to-device时间作为STEMI救治质量的核心监测指标。
- 低绩效医院需针对急诊停留、导管室到PCI时间及转运延迟等环节改进流程。
局限性
- 回顾性横断面设计,仅能提示关联而非因果。
- 数据来自质量改进注册研究,可能存在选择偏倚和未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Percutaneous coronary intervention (PCI) is the criterion standard for acute ST-elevation myocardial infarction (STEMI). Achieving target first medical contact (FMC)-to-device time is a quality metric in STEMI care. OBJECTIVES: To describe site-level variability in achieving target FMC-to-device time (≤90 minutes for primary presentations to PCI-capable hospitals and ≤120 minutes for transfers), compare treatment times according to hospital performance, location, and primary PCI volume, and assess whether these aspects are associated with clinical outcomes. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cross-sectional study from the American Heart Association Get With the Guidelines-Coronary Artery Disease registry from 2020 to 2022. Patients were recruited from a multicenter quality-improvement registry across 503 US hospitals. Patients with STEMI or STEMI equivalent who underwent primary PCI were included in this analysis. EXPOSURES: FMC-to-device time. MAIN OUTCOMES AND MEASURES: Hospital performance was determined by the proportion of patients meeting target FMC-to-device time at each site. Treatment times and outcomes were compared by hospital performance, location, and primary PCI volume. RESULTS: A total of 73 826 patients were analyzed (median [IQR] age, 62 [54-71] years; 53 474 male [72.4%]). Of 60 109 patients who presented directly to PCI-capable hospitals (primary presentations), 35 783 (59.5%) achieved an FMC-to-device time of 90 minutes or less, whereas 6900 (50.3%) of 13 717 transfers had an FMC-to-device time of 120 minutes or less. There was substantial institutional variability in achieving target FMC-to-device time for both primary presentations (median [IQR], 60.8% [51.2%-68.8%]) and transfers (median [IQR], 50.0% [32.5%-66.9%]). High-performing centers met all target treatment times more frequently. Low-performing sites experienced prolonged emergency department stays, catheterization laboratory arrival-to-PCI times, and transfer delays, varying by mode of presentation. Compared with urban centers, presentation to rural hospitals did not affect the odds of meeting target FMC-to-device time for primary presentations (adjusted odds ratio [aOR], 1.20; 95% CI, 0.96-1.50) or transfers (aOR, 0.86; 95% CI, 0.50-1.47). Failure to achieve target FMC-to-device time was associated with increased in-hospital mortality risk for primary presentations (aOR, 2.21; 95% CI, 2.02-2.42) and transfers (aOR, 2.44; 95% CI, 1.90-3.12). Low hospital performance was associated with increased mortality risk compared with high performance in primary presentations (aOR, 1.16; 95% CI, 1.00-1.34). Outcomes were similar between rural vs urban and low vs high primary PCI volume centers. CONCLUSIONS AND RELEVANCE: In this large cross-sectional study of patients with STEMI, there was substantial hospital-level variability in achieving target treatment times. Patients in whom target FMC-to-device time was not met and those presenting to low-performing hospitals had worse outcomes.
引用
- Sammour YM, Khan SU, Hong H, et al. Institutional Variability in Processes of Care and Outcomes Among Patients With STEMI in the US. JAMA Cardiol. 2025. PMID: 40498491. doi:10.1001/jamacardio.2025.1411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。